Sardano Joseph C
CHIEF EXECUTIVE OFFICER
Sardano Joseph C has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 24, 2026.
On the most recent filing, Sardano Joseph C is listed as CHIEF EXECUTIVE OFFICER at Sensus Healthcare, Inc. Inside the rolling window, Sardano Joseph C reported 2 open-market purchases totaling $161K in SRTS and no open-market sales. The largest disclosed transaction in the window is a purchase of 25,000 SRTS shares on Nov 18, 2025, worth $101K.
Companies traded
Other insiders at SRTS
Insider Buying
$161K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sardano Joseph C made?
Sardano Joseph C has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Sardano Joseph C trade?
Sardano Joseph C has filed SEC Form 4 disclosures for 1 company, including SRTS.
When was Sardano Joseph C's most recent SEC Form 4 filing?
Sardano Joseph C's most recent SEC Form 4 filing on Tracefour is dated Aug 24, 2026.
What is Sardano Joseph C's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sardano Joseph C is listed as CHIEF EXECUTIVE OFFICER.
What is Sardano Joseph C's total buy and sell value in the current window?
Inside the rolling retention window, Sardano Joseph C bought $161K and sold $0 based on SEC Form 4 filings.
What was Sardano Joseph C's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 25,000 SRTS shares on 2025-11-18, worth $101K, per SEC Form 4 filings.